Literature DB >> 16433899

Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway.

Wen-Feng Chu1, Hong-Li Sun, De-Li Dong, Guo-Fen Qiao, Bao-Feng Yang.   

Abstract

We used Fluo-3/AM to examine the effect of platelet-activating factor on the intracellular Ca2+([Ca2+]i) levels in isolated myocytes of guinea pig ventricle. Myocytes were isolated with Langendorff perfusion technique and were challenged with platelet-activating factor. Addition of platelet-activating factor (1 pM to 10 nM) significantly increased the [Ca2+]i in the presence and absence of extracellular Ca2+. The notion that increases in intracellular Ca2+ induced by platelet-activating factor is the result of stimulation of intracellular Ca2+ pool rather than increasing Ca2+ influx was further supported by the whole cell patch-clamp experiments in which the platelet-activating factor did not alter the activity of L-type of Ca2+ channels (I(Ca-L)). Treatment of myocytes with ryanodine failed to abolish the stimulatory effect of platelet-activating factor on [Ca2+]i. In contrast, inhibition of IP3-sensitive Ca2+ release pool with 2-aminoethoxydiphenyl borate (2-APB) blocked the effect of platelet-activating factor. We conclude that the platelet-activating factor-induced increase in intracellular Ca2+ is mediated by stimulation of IP3 receptor but not by stimulation of I(Ca-L) and ryanodine-sensitive receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433899     DOI: 10.1111/j.1742-7843.2006.pto_313.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  5 in total

1.  Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway.

Authors:  M J Wacker; L M Kosloski; W J R Gilbert; C D Touchberry; D S Moore; J K Kelly; M Brotto; J A Orr
Journal:  J Pharmacol Exp Ther       Date:  2009-09-09       Impact factor: 4.030

2.  Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB.

Authors:  Chad D Touchberry; Neerupma Silswal; Vladimir Tchikrizov; Christopher J Elmore; Shubra Srinivas; Adil S Akthar; Hannah K Swan; Lori A Wetmore; Michael J Wacker
Journal:  BMC Pharmacol Toxicol       Date:  2014-12-17       Impact factor: 2.483

Review 3.  Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Hang Yin; Anhua Shi; Junzi Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-08       Impact factor: 3.249

4.  A novel Danshensu/tetramethylpyrazine protects against Myocardial Ischemia Reperfusion Injury in rats.

Authors:  Jinghao Wang; Kai Fan; Cong He; Qingyang Wang; Qianhui Zhang; Wei Huang
Journal:  Int J Med Sci       Date:  2021-05-13       Impact factor: 3.738

5.  Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation.

Authors:  Ying Zhang; Renjun Wang; Weijie Du; Shuxuan Wang; Lei Yang; Zhenwei Pan; Xuelian Li; Xuehui Xiong; Hua He; Yongfang Shi; Xue Liu; Shaonan Yu; Zhengang Bi; Yanjie Lu; Hongli Shan
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.